Guided Therapeutics Inc (GTHP) shareholders
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Ownership
Who owns Guided Therapeutics's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Auctus Fund Management LLC Joint filing with Auctus Fund, LLC (9.90%), Alfred Sollami (9.90%) and 1 more | 5,804,865 | 9.90% | 13G (passive) amendment | Sep 30, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John E. Imhoff | Director, 10% owner | 22,902,888 | 23.72% | Oct 27, 2026 |
| Richard P. Blumberg | Director, 10% owner | 13,543,130 | 14.03% | May 5, 2026 |
| Michael C. James | Director | 1,001,863 | 1.04% | Apr 7, 2026 |
| Alan Grujic | Director | 1,817,541 | 1.88% | Apr 7, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John E. Imhoff Director, 10% owner | Sep 30, 2026 | Conversion | +1,650,215 | $0.07 | $115.52K | 22,902,888 |
| John E. Imhoff Director, 10% owner | Mar 31, 2026 | Conversion | +157,417 | $0.07 | $11.02K | 21,252,673 |
| Richard P. Blumberg Director, 10% owner | Mar 26, 2026 | Other | +1,040,000 | – | – | 10,020,273 |
| Richard P. Blumberg Director, 10% owner | Mar 26, 2026 | Other | −88 | – | – | 0 |
| Richard P. Blumberg Director, 10% owner | Mar 26, 2026 | Other | +19,038 | – | – | 10,039,311 |
| Richard P. Blumberg Director, 10% owner | Mar 26, 2026 | Other | +352,000 | – | – | 10,391,311 |
| Richard P. Blumberg Director, 10% owner | Mar 26, 2026 | Other | −260 | – | – | 0 |
| Richard P. Blumberg Director, 10% owner | Mar 26, 2026 | Other | +56,093 | – | – | 8,980,273 |
| John E. Imhoff Director, 10% owner | Mar 26, 2026 | Other | −10 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 26, 2026 | Other | +2,157 | – | – | 21,055,256 |
| John E. Imhoff Director, 10% owner | Mar 26, 2026 | Other | +40,000 | – | – | 21,095,256 |
| John E. Imhoff Director, 10% owner | Feb 27, 2026 | Other | −100 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Feb 27, 2026 | Other | +400,000 | – | – | 20,897,013 |
| John E. Imhoff Director, 10% owner | Feb 27, 2026 | Conversion | +156,086 | $0.07 | $10.93K | 21,053,099 |
| Richard P. Blumberg Director, 10% owner | Feb 25, 2026 | Option exercise | +1,000,000 | – | – | 8,924,180 |
| John E. Imhoff Director, 10% owner | Feb 25, 2026 | Option exercise | +500,000 | – | – | 20,497,013 |
| Michael C. James Director | Feb 25, 2026 | Option exercise | +100,000 | – | – | 653,495 |
| John E. Imhoff Director, 10% owner | Feb 2, 2026 | Conversion | +312,720 | $0.07 | $21.89K | 19,997,013 |
| John E. Imhoff Director, 10% owner | Jan 5, 2026 | Other | +25,338 | – | – | 19,684,293 |
| John E. Imhoff Director, 10% owner | Dec 18, 2025 | Conversion | +195,460 | $0.07 | $13.68K | 19,658,955 |
| Alan Grujic Director | Aug 29, 2025 | Buy | +152,108 | – | – | 1,817,541 |
| John E. Imhoff Director, 10% owner | Aug 29, 2025 | Buy | +166,667 | $0.18 | $30.00K | 19,463,495 |
| Michael C. James Director | Aug 29, 2025 | Buy | +27,778 | $0.18 | $5.00K | 553,495 |
| Alan Grujic Director | Aug 21, 2025 | Other | +200,000 | – | – | 1,665,433 |
| Alan Grujic Director | Aug 21, 2025 | Other | +17,408 | – | – | 1,465,433 |
| Alan Grujic Director | Aug 21, 2025 | Other | −50 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Aug 21, 2025 | Other | −300 | – | – | 100 |
| John E. Imhoff Director, 10% owner | Aug 21, 2025 | Other | +104,448 | – | – | 18,096,828 |
| John E. Imhoff Director, 10% owner | Aug 21, 2025 | Other | +1,200,000 | – | – | 19,296,828 |
| Richard P. Blumberg Director, 10% owner | Aug 21, 2025 | Other | +932,000 | – | – | 7,924,180 |
| Richard P. Blumberg Director, 10% owner | Aug 21, 2025 | Other | −233 | – | – | 0 |
| Richard P. Blumberg Director, 10% owner | Aug 21, 2025 | Other | +81,121 | – | – | 6,992,180 |
| Richard P. Blumberg Director, 10% owner | Apr 10, 2025 | Other | +55,853 | – | – | 6,911,059 |
| Richard P. Blumberg Director, 10% owner | Apr 10, 2025 | Other | +165,481 | – | – | 6,855,206 |
| John E. Imhoff Director, 10% owner | Apr 10, 2025 | Other | +6,365 | – | – | 17,992,380 |
| John E. Imhoff Director, 10% owner | Apr 10, 2025 | Other | +6,365 | – | – | 17,992,380 |
| John E. Imhoff Director, 10% owner | Mar 18, 2025 | Buy | +1,000,000 | $0.10 | $100.00K | 17,722,946 |
| John E. Imhoff Director, 10% owner | Mar 18, 2025 | Buy | +263,069 | $0.10 | $26.31K | 17,986,015 |
| John E. Imhoff Director, 10% owner | Mar 18, 2025 | Buy | +263,069 | $0.10 | $26.31K | 17,986,015 |
| John E. Imhoff Director, 10% owner | Mar 18, 2025 | Buy | +1,000,000 | $0.10 | $100.00K | 17,722,946 |
| Michael C. James Director | Mar 18, 2025 | Buy | +150,000 | $0.10 | $15.00K | 262,772 |
| Michael C. James Director | Mar 18, 2025 | Buy | +262,945 | $0.10 | $26.29K | 525,717 |
| John E. Imhoff Director, 10% owner | Mar 13, 2025 | Buy | +150 | – | – | 400 |
| John E. Imhoff Director, 10% owner | Mar 11, 2025 | Other | −286 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 11, 2025 | Other | +2,258,690 | $0.13 | $293.63K | 16,722,946 |
| John E. Imhoff Director, 10% owner | Mar 11, 2025 | Other | −286 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 11, 2025 | Other | +2,258,690 | $0.13 | $293.63K | 16,722,946 |
| John E. Imhoff Director, 10% owner | Mar 7, 2025 | Buy | +286 | – | – | 286 |
| John E. Imhoff Director, 10% owner | Mar 7, 2025 | Buy | +286 | – | – | 286 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | +4,801,500 | $0.50 | $2.40M | 14,464,256 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | −2,400.75 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | −300 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | +900,000 | – | – | 9,662,756 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | +4,801,500 | $0.50 | $2.40M | 14,464,256 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | −300 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | −2,400.75 | – | – | 0 |
| John E. Imhoff Director, 10% owner | Mar 6, 2025 | Other | +900,000 | – | – | 9,662,756 |
| John E. Imhoff 10% owner | Jan 17, 2025 | Other | +35,312 | – | – | 8,762,756 |
| John E. Imhoff Director, 10% owner | Dec 18, 2024 | Buy | +1,615,385 | – | – | 8,727,444 |
| John E. Imhoff Director, 10% owner | Oct 15, 2024 | Other | +36,161 | – | – | 7,112,059 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Guided Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,275 shares on Sep 22, 2026 over the last 90 days.
See a number that looks wrong?